Henry Schein Inc. (HSIC) Issues FY14 Earnings Guidance
Henry Schein Inc. (NASDAQ:HSIC) updated its FY14 earnings guidance on Tuesday. The company provided earnings per share guidance of $5.29-5.39 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $5.42, Stock Ratings Network.com reports.
On a related note, analysts at Zacks reiterated a neutral rating on shares of Henry Schein in a research note on Friday, December 13th. They now have a $117.00 price target on the stock. One research analyst has rated the stock with a sell rating, four have issued a hold rating and two have given a buy rating to the stock. The stock presently has an average rating of Hold and a consensus price target of $97.14.
Shares of Henry Schein Inc. (NASDAQ:HSIC) opened at 114.84 on Tuesday. Henry Schein Inc. has a 52 week low of $86.67 and a 52 week high of $118.52. The stock’s 50-day moving average is $114.5 and its 200-day moving average is $109.. The company has a market cap of $9.859 billion and a P/E ratio of 23.85.
Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings data on Tuesday, February 11th. The company reported $1.43 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.39 by $0.04. The company had revenue of $2.50 billion for the quarter, compared to the consensus estimate of $2.53 billion. During the same quarter in the prior year, the company posted $1.26 earnings per share. The company’s quarterly revenue was up 4.9% on a year-over-year basis. On average, analysts predict that Henry Schein Inc. will post $4.90 earnings per share for the current fiscal year.
Henry Schein, Inc is a provider of health care products and services to office-based practitioners. The Company conducts its business through two segments: healthcare distribution and technology.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.